ZTS: Zoetis Inc. Financials
ZTS Income Statement
Total revenue
Net income
Gross margin TTM
70.49%
Operating margin TTM
38%
Net profit margin TTM
28.23%
Return on investment TTM
—
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 9,467,000,000 | 9,256,000,000 | 8,544,000,000 | 8,080,000,000 |
| Operating income | 3,597,000,000 | 3,392,000,000 | 3,069,000,000 | 2,928,000,000 |
| Net income | 2,673,000,000 | 2,486,000,000 | 2,344,000,000 | 2,114,000,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 9,467,000,000 | 9,256,000,000 | 8,544,000,000 | 8,080,000,000 |
| Cost of revenue | 2,794,000,000 | 2,860,000,000 | 2,710,000,000 | 2,604,000,000 |
| Gross profit | 6,673,000,000 | 6,396,000,000 | 5,834,000,000 | 5,476,000,000 |
| Research and development expenses | 698,000,000 | 686,000,000 | 614,000,000 | 539,000,000 |
| General and administrative expenses | 0 | 2,016,000,000 | 0 | 0 |
| Selling and marketing expenses | 0 | 302,000,000 | 0 | 0 |
| Selling, general and administrative expenses | 2,378,000,000 | 2,318,000,000 | 2,151,000,000 | 2,009,000,000 |
| Other expenses | 0 | 0 | 0 | 0 |
| Operating expenses | 3,076,000,000 | 3,004,000,000 | 2,765,000,000 | 2,548,000,000 |
| Cost and expenses | 5,870,000,000 | 5,864,000,000 | 5,475,000,000 | 5,152,000,000 |
| Net interest income | -150,000,000 | -136,000,000 | -153,000,000 | -187,000,000 |
| Interest income | 93,000,000 | 106,000,000 | 105,000,000 | 50,000,000 |
| Interest expense | 243,000,000 | 242,000,000 | 258,000,000 | 237,000,000 |
| Depreciation and amortization | 487,000,000 | 497,000,000 | 491,000,000 | 465,000,000 |
| EBITDA | 4,069,000,000 | 3,872,000,000 | 3,685,000,000 | 3,358,000,000 |
| EBIT | 3,582,000,000 | 3,375,000,000 | 3,194,000,000 | 2,893,000,000 |
| Non-operating income (excl. interest) | 15,000,000 | 17,000,000 | -125,000,000 | 35,000,000 |
| Operating income | 3,597,000,000 | 3,392,000,000 | 3,069,000,000 | 2,928,000,000 |
| Total other income/expenses (net) | -237,000,000 | -259,000,000 | -133,000,000 | -272,000,000 |
| Income before tax | 3,360,000,000 | 3,133,000,000 | 2,936,000,000 | 2,656,000,000 |
| Income tax expense | 687,000,000 | 637,000,000 | 596,000,000 | 545,000,000 |
| Net income from continuing operations | 2,673,000,000 | 2,496,000,000 | 2,340,000,000 | 2,111,000,000 |
| Net income from discontinued operations | 0 | 0 | 0 | 0 |
| Other adjustments to net income | 0 | 0 | 0 | 0 |
| Net income | 2,673,000,000 | 2,486,000,000 | 2,344,000,000 | 2,114,000,000 |
| Net income deductions | 0 | 0 | 0 | 0 |
| Bottom line net income | 2,673,000,000 | 2,486,000,000 | 2,344,000,000 | 2,114,000,000 |
| EPS | 6 | 5 | 5 | 5 |
| Diluted EPS | 6 | 5 | 5 | 4 |
| Weighted average shares outstanding | 443,443,000 | 454,200,000 | 461,172,000 | 468,891,000 |
| Weighted average diluted shares outstanding | 443,835,000 | 454,848,000 | 462,269,000 | 470,385,000 |